OxyElite Pro: Health Advisory - Acute Hepatitis Illness Cases Linked To Product Use
FDA advises consumers to stop using products labeled OxyElite Pro while the investigation continues.
Italiano
FDA advises consumers to stop using products labeled OxyElite Pro while the investigation continues.
In extreme cases, may cause a failure of the automatic ventilation function of the device.
Atossa will remove existing product from the market until concerns are addressed.
May result in local inflammation, phlebitis, and/or low-level allergic response, and could block administration of the drug to the patient, causing a delay in therapy.
Defect due to a reduction in package density, a higher than average dose of gamma sterilization, and the occasional slippage of a protective silicon sleeve during shipping.
Administration of an injectable with the presence of foreign particulates may result in local inflammation,
thrombophlebitis, and/or low-level allergic response.
80.211.154.110